Trastornoslipídicosenpacienteshispanoamericanosen el primer nivel de atención sanitaria de Lima, Perú

Introduction: Dyslipidemia is a risk factor for the development of cardiovascular diseases, which are considered to be the main cause of death at the global level. Objectives: To assess lipid disorders in Hispanic Americans patients in the primary health care level in Lima. Methods: In the period 2015-2016 a prospective research was made in 117 patients of the Service of Clinical Laboratory, La Fe Policlinic in Lima. There were used the guides named National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III), US Preventive Services Task Force, and the clinical practice guidelines of the Mexican Institute of Social Security. The lipid variables were established in accordance with each guide: High Triglycerides (TG) (TG ≥150 mg/dl) and high total cholesterol (CT ≥ 200 mg/dl), High LDL-C cholesterol (LDL-C ≥ 130 mg/dl) and decreased HDL-C (HDL-C ≤ 40 mg/dl). Results: 71 % of the patients presented decreased HDL-C, 41 % hypertriacilglyceridemia, 35.9 % hypercholesterolemia and 33.3 % high LDL-C. According to the US Preventive Services Task Force guide 9 patients with dyslipidemia grade B were identified by the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III) guide, and 99 patients in 4 groups of dyslipidemia and 5 patients without lipid disorders were identified according to the clinical practice guidelines of the Mexican Institute of Social Security. Conclusions: It is observed a high frequency of patients with lipid disorders mainly by decreased HDL-C and there is evidence of the advantages of the clinical practice guidelines in the primary level of health care.